Upbound Group: cheap on every method, but thin equity needs a wider margin

Upbound Group, the owner of Acima, Rent-A-Center and Brigit, looks cheap on every method used here. The market is pricing a business that shrinks forever. But common equity is only about 40% of enterprise value, and a regulator is arguing that lease-to-own is really lending. That combination needs a wider margin than the price offers today.

At $16.89 on September 21, 2026, the shares trade 27.1% below my triangulated Base value of $23.16, an upside of 37.1%. The Bear value of $12.89 is still 23.7% below the price, and the required margin of safety of 50% puts the maximum buy price at $11.58. For existing holders the dividend is covered and the valuation is undemanding, so this is a hold. For new money it is a watchlist name.

Route: SF-11 Retail and Consumer, lease-to-own subtype with a consumer finance overlay. Economic classification: Standard Company (2/12). Primary method: EV to hard EBITDA, after stock compensation and normalized legal costs. Secondary method: normalized owner free cash flow. Values are capitalized estimates, not 12-month price targets.

What Upbound is

Upbound serves consumers who do not qualify for traditional credit. Acima offers virtual lease-to-own at the checkout of partner retailers and is about 53% of revenue. Rent-A-Center runs the store-based lease-to-own business. Brigit, acquired in January 2025, is an app offering cash advances and financial tools on a subscription. A small Mexico segment completes the group.

The company is classified as specialty retail, but its economics behave like non-prime consumer credit. That is why group-wide gross margin and same-store sales are not used as quality signals. The analysis tracks Acima GMV and lease charge-offs, Rent-A-Center same-store sales, and Brigit subscribers and loss rates instead.

The character of the business has changed, from a store retailer to a hybrid lease-to-own and fintech platform. That shift moves it into a riskier class, and it is the main reason the low end of the sector multiple range is used and the verdict is lowered by one notch.

The latest quarter

Acima is buying margin with volume, and Brigit is the only segment that is clearly growing. Full-year guidance is revenue of $4.70 to $4.85 billion, Adjusted EBITDA of $500 to $535 million and non-GAAP EPS of $4.00 to $4.35. Q3 guidance of $105 to $115 million of EBITDA sits below last year's $123.6 million, so reaching the full-year midpoint needs a Q4 of about $144 million, up roughly 15%. That back-loaded year is the first credibility test.

Why headline free cash flow overstates the business

Data aggregators show trailing free cash flow of about $356 million and a P/FCF near 2.8x. That number should not anchor a valuation. In lease-to-own, merchandise purchases run through operating cash flow, so when the lease portfolio shrinks, cash is released. Acima GMV fell 10.7% in Q2, so part of today's strong cash flow is a shrinking book, not recurring earning power. Free cash flow in this business is countercyclical. The aggregator figure also ignores Brigit cash advances, which the company itself deducts.

$ million.

The swings follow the portfolio: 2022 was strong as the book shrank, 2024 was weak as Acima grew again. Averaging across the cycle captures both. Less about $20 million of recurring stock compensation, the average is about $203 million. A structural build from hard EBITDA of $485.5 million, less about $105 million of interest, $70 million of capex, $85 million of cash taxes and $25 million of portfolio growth, gives about $201 million. Normalized owner FCF is therefore set at $200 million, or $3.39 per share, about 56% of the headline figure and 80% of the company's raised 2026 FCF outlook of about $250 million.

Debt, shares and the equity bridge

Net debt is an estimate: the company reported about $1.3 billion and net leverage of 2.6x against trailing Adjusted EBITDA of about $512.6 million. The Brigit earnout depends on 2026 performance. Its fair value at the acquisition date was $10.6 million, but Brigit is running well ahead of that plan, so a current value of $20 million is assumed. The full range from $10.6 to $60 million moves the Base by less than $1 per share. Operating leases are excluded consistently, because EBITDA is measured after rent.

The share count is 59.0 million diluted shares. Diluted shares fell from 66.9 million in 2021 to 55.0 million in 2023, then rose to about 58.7 million in 2025 because Brigit was partly paid in stock.

Primary valuation: EV to hard EBITDA

Divided by 59.0 million shares, the primary Base value is $20.72. Company Adjusted EBITDA adds back stock compensation and excludes legal matters, so both are deducted here. The 5.5x multiple sits at the low end of the framework's range for struggling retail, reflecting credit and regulatory risk. Each half turn of the multiple is worth about $4.11 per share, which shows how thin the equity slice is.

Secondary valuation: owner FCF

Normalized owner FCF of $200 million at 8.5x gives $1,700 million. Net debt is not subtracted again, because this cash flow is already after interest. The deferred consideration, earnout and legal accrual, $117.7 million in total, are subtracted, leaving $1,582.3 million, or $26.82 per share. The 8.5x multiple is the framework's cyclical level of 9x, less half a turn for dilution from the Brigit deal.

Historical cross-check

Using year-end prices implied by aggregator dividend yields and reported leverage, Upbound traded at about 5.8x Adjusted EBITDA at the end of 2024 and about 4.8x at the end of 2025. It trades at about 4.7x today. A 5.3x historical midpoint on the 2026 guidance gives about $21.95 per share, close to the triangulated Base. Peer PROG Holdings has traded at roughly 3.6x to 4.4x on a different EBITDA definition and a different date, so it is not used as a synchronized comparison.

Valuation triangulation

The EBITDA method gets more weight because it is the sector-appropriate measure and less exposed to working capital swings. The two methods diverge by 25.7%, inside the framework's warning band but below the 30% flag. The gap comes from multiple choice: 8.5x levered cash flow is equivalent to about 6.2x hard EBITDA, above the 5.5x used in the primary method.

What is the market already pricing in?

At $16.89, market equity is about $996.5 million and enterprise value, including the debt-like items, about $2,444 million. That is about 5.0x hard EBITDA, or 4.7x company Adjusted EBITDA guidance. On the cash method, at a 13% cost of equity, the price implies owner FCF of about $145 million held flat forever, or $200 million shrinking by about 4.2% a year in perpetuity.

An investor does not need a growth story to see value here. The stock only needs the business not to shrink permanently. The risk is not the operating case. It is whether regulation changes the economics before the cash arrives.

Bear, base and bull scenarios

Bear: non-prime stress takes hard EBITDA back to roughly 2023 levels, Acima keeps shrinking and a larger settlement arrives. The multiple is cut by only half a turn, for regulatory recharacterization risk, because a cyclical trough alone does not justify double pessimism. Base: 2026 guidance is met and credit stays under control. Bull: Acima volume returns, Brigit keeps compounding and the multiple recovers toward the company's own history.

The probability-weighted value is $22.35, 32% above the price.

Sensitivity

The range from $7.92 to $31.70 on the primary method alone is the practical reason for a wide margin of safety.

How the buy price is set

A 50% discount to the $23.16 Base gives a maximum buy price of $11.58. The leverage modifier is kept even though net leverage of 2.6x is not acute: equity is only about 40% of enterprise value, so any error in the enterprise estimate is amplified about two and a half times in the share value. No separate cyclicality modifier is added, because the low multiple and the Bear case already carry it.

If the regulatory matters were resolved on manageable terms, the requirement would fall to 40% and the buy price would rise to about $13.90. Leverage at 2.0x, the company's target, would move it further.

Dividend

The quarterly dividend is $0.39, or $1.56 a year, a 9.2% yield at $16.89. It costs about $92 million a year, covered 2.2x by normalized owner FCF. On GAAP earnings the payout is about 101%, on non-GAAP EPS guidance about 37%. The dividend has grown for four years but has been held at $0.39 since the Q1 2025 increase. It is covered today, but it is not immune to a large settlement or a credit downturn.

Reasons to own UPBD

• The price assumes decline. At about 4.7x Adjusted EBITDA the market prices a permanently shrinking business. A flat outcome is worth about $23.
• Credit discipline is working. Acima's lease charge-off rate is below 9% and its EBITDA margin above 16%. Proprietary underwriting data is the closest thing to a moat here.
• Brigit is a real growth engine. Revenue grows more than 30% a year, and the app is a data and cross-selling hub for the group.
• Deleveraging and cash returns. Net leverage fell from 2.9x at the end of 2025 to 2.6x, with a 2.0x target, while the dividend stays covered.

What could go wrong?

• Regulatory recharacterization. The New York Attorney General argues that Acima's lease-to-own transactions are loans. An adverse ruling or a broad multistate settlement could bring rate caps and large payments. This is the main thesis breaker.
• Non-prime credit stress. Lease charge-offs above 10% at Acima or rising Brigit advance losses would hit earnings while debt is still 2.6x EBITDA.
• Thin equity. Enterprise value is about $2.4 billion against a market value of about $1.0 billion, so modest enterprise value deterioration destroys a disproportionate share of equity value.
• Recurring one-offs. Legal special items were about $76 million in 2025. If exclusions from adjusted metrics keep recurring, adjusted EBITDA overstates earning power.
• Execution. The back-loaded Q4 guidance and remediation after the fraud losses are near-term tests.

Management execution

On the positive side, guidance has been delivered and leverage is coming down. On the negative side, $411 million of buybacks in 2021 were made at much higher prices, the Brigit deal diluted shareholders and added an earnout, and recurring legal costs are routinely excluded from adjusted figures. Management credibility scores 10/20, a mixed record.

Stock Analyza scorecard

Under the framework's classification, the stock is deeply undervalued against Base, but the required margin of safety is not met.

Confidence score

What I would watch from here

The next review point is Q3 2026 results, expected around October 29, 2026. Q3 EBITDA must land within the $105 to $115 million range, and full-year guidance must hold.

The three most important thesis breakers

1. A regulatory ruling or settlement that recharacterizes lease-to-own or cash advances as credit.
2. Acima lease charge-offs above 10% in a consumer downturn.
3. Leverage above 3.0x together with falling EBITDA.

Adversarial review

The first version of this analysis set a 60% margin of safety and a maximum buy price of $8.80. An external adversarial audit challenged it, and the review accepted most of the challenge. A permanent $25 million legal cost deduction was cut to $10 million, because first-half 2026 legal charges were only about $3 million and the large 2025 charges already sit in the $60.2 million accrual, which is deducted separately. The earnout estimate was cut from $30 million to $20 million. With both corrections the divergence between methods fell from 34% to 25.7%, removing a valuation divergence penalty, and a separate cyclicality modifier was dropped as double counting.

One challenge was rejected. The audit argued that leverage was already reflected in the multiple and should not add to the margin of safety. The margin of safety measures the risk that the value estimate is wrong, and leverage amplifies that error into the equity, so the modifier stays. The audit's own figures put the maximum buy price at about $13.10. The two versions agree on the verdict.

Every test gives a value above the $16.89 price, and none gives a buy price above it. Analyst consensus is a buy with a $28.25 target; the gap to this Base comes from deducting stock compensation and legal costs and from a lower multiple. Short interest of about 13% of the float is a reminder that bears are betting on the regulatory outcome. The publication gate status is PASS_WITH_WARNING.

Final verdict: hold at $16.89, watchlist for new money

Upbound is genuinely inexpensive on normalized economics, and the dividend is covered. But debt sits ahead of a thin slice of equity, and the central regulatory question is unresolved. The price does not yet compensate for that combination.

Verdict: HOLD at $16.89, WATCHLIST for new money. Triangulated Base value $23.16, upside 37.1%, Confidence C (14/25). Required margin of safety 50%, maximum buy price $11.58.

For an existing holder, the dividend and the discount to Base support holding. Adding makes sense at or below the buy price, or after a manageable regulatory resolution lowers the required margin.

The main thesis breaker is an adverse New York Attorney General or multistate outcome that treats lease-to-own as credit.

Sources

Primary sources include Upbound's Q2 2026 results, the Q2 2026 supplemental tables, the June 2026 Form 10-Q, the September 2025 Form 10-Q for the earnout fair value, and the Brigit acquisition Form 8-K. Historical cash flow, share counts, dividend yields and the market price come from a third-party market data aggregator and serve as secondary inputs.

The reference market price is $16.89, the regular session close on September 21, 2026. Balance sheet figures are as of June 30, 2026. Net debt and the earnout are estimates, as explained above.